With the introduction of new CPT codes, laboratories will soon be one big step closer to seeing added reimbursement for the value they deliver with digital pathology.
UCF researchers have found a new way to track metastatic cancer cells in the body, which in the future could help identify cancer earlier and give patients more treatment options.
Artificial intelligence (AI), particularly machine learning technologies, are transforming pathology workflows. By automating various steps in tissue analysis, AI algorithms accelerate diagnosis and improve diagnostic accuracy. However, the ability of humans to interpret AI algorithms is low, further complicating their regulatory approval for clinical use and limiting their widespread clinical adoption. To overcome challenges associated with AI interpretability, researchers have developed explainable AI (xAI) models. Nevertheless, there are no widely accepted criteria for determining the explainability of AI algorithms, and studies assessing the experience of clinicians with AI models are lacking.
Investigators found that patients with severe COVID-19 had clots in small venous and arterial blood vessels acting as COVID-19 markers.
Okayama University: Researchers have developed a new AI model which diagnoses and classifies neoplastic lesions in patients with IBD with high accuracy.
Digital pathology is supposed to help pathologists provide better patient care and make their lives easier, but what about other doctors, do they even care? Maybe radiologists? Oncologists? Nope…Dermatologists! They do care!
Mike Miller, I. Miller Microscopes A common misconception about digital pathology is that it is synonymous with whole slide imaging and has a high price point. This is not the case, as one can enter the digital pathology world and benefit from what it has to offer with a simple microscope camera. If we would [...]
HCG: This collaboration is expected to significantly reduce the turnaround time, standardise reporting quality and increase efficiency multi-fold. Further, this solution will enable pathologists to collaborate seamlessly across geographies thereby ensuring that every HCG centre will now get access to expertise across the network within seconds.HealthCare Global Enterprises Ltd (HCG), an Indian specialty healthcare services hospital focused on oncology has deployed Sigtuple’s AI100 to equip the Hematopathology labs across its network with AI-powered screening solutions for cancer detection and disease management.The screening tool enables AI-assisted digital hematopathology to automate the manual microscopy (screening) process across its network.As manual microscopy is still the standard in diagnosing several critical disorders like cancers, infections, etc., in the absence of a pathologist at site in laboratories outside urban areas, these samples need to be shipped to central reference laboratories for review.Apart from the logistic challenges and associated delays in turnaround times, there is also limited expertise available for providing high-quality diagnostics at remote locations.“AI-assisted digital scanning technology has indeed emerged as a game-changer in cancer care. Sigtuple’s best-in-class solution has brought remarkable precision to HCG’s Hematopathology diagnostic capabilities. The automation of key processes and optimization of logistics by virtue of this pioneering technology is a distinct value-add for HCG, given our overarching goal of serving the larger cause of patients through enhanced clinical outcomes,” stated Dr. B.S. Ajaikumar, Executive Chairman, HCG.World over, it is strongly believed that artificial intelligence-assisted digital scanning technology is the way forward for pathology. Digital scanning technology makes it possible for pathologists to review samples remotely, without having to ship them to the reference laboratory, as the digital conversion can happen at site.This collaboration is expected to significantly reduce the turnaround time, standardise reporting quality and increase efficiency multi-fold. Further, this solution will enable pathologists to collaborate seamlessly across geographies thereby ensuring that every HCG centre will now get access to expertise across the network within seconds.SOURCE: Business World
Dr. Michael Grunkin, Founder and CEO at Visiopharm With the regulatory approvals of whole slide imaging systems, digital pathology became the modality for routine diagnostics. Digitalization of pathology is aiming at increasing precision and productivity in the pathology lab, but the adoption of this field is slower than expected. One of the causes of the [...]
London, 27 June 2022 - An innovative partnership between East Kent Hospitals and digital pathology company Source LDPath, a part of SourceBio International plc, is helping to reduce pathology waiting times and improve patient care. The Trust has teamed up with Source LDPath to send digital images of slides to their network of pathologists so they can [...]
